Young Adults With Early-onset Obesity Treated With Semaglutide — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Young Adults With Early-onset Obesity Treated With Semaglutide — Stella

Recruiting

Back to Obesity, Adolescent trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(2 sites)

Denmark

Holbæk University Hospital, Holbæk, Region Zeeland

University of Copenhagen, Department of Biomedical Sciences, Copenhagen

Key details

Phase

Post-approval study

Sponsor

Signe Torekov

Collaborators

University of Leeds, Karolinska Institutet

Enrollment target

~180 participants

Started

June 2022

Primary completion

April 2026

Age range

18 Years – 28 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov